vs
Karat Packaging Inc.（KRT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Karat Packaging Inc.的1.9倍（$219.9M vs $115.6M），Karat Packaging Inc.净利率更高（5.9% vs -1.0%，领先6.9%），Karat Packaging Inc.同比增速更快（13.7% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $15.1M），过去两年Karat Packaging Inc.的营收复合增速更高（10.0% vs 8.0%）
Karat Packaging Inc.是专业一次性餐饮包装产品生产商及分销商，产品涵盖纸塑杯、食品容器、餐具、杯盖及定制品牌包装方案，主要服务北美地区的连锁餐厅、咖啡馆、餐饮服务商及零售食品客户。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
KRT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$115.6M
营收增速更快
KRT
高出11.8%
2.0%
净利率更高
KRT
高出6.9%
-1.0%
自由现金流更多
OFIX
多$1.7M
$15.1M
两年增速更快
KRT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $219.9M |
| 净利润 | $6.8M | $-2.2M |
| 毛利率 | 34.0% | 71.1% |
| 营业利润率 | 7.3% | 0.2% |
| 净利率 | 5.9% | -1.0% |
| 营收同比 | 13.7% | 2.0% |
| 净利润同比 | 21.3% | 92.4% |
| 每股收益（稀释后） | $0.34 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRTOFIX
| Q4 25 | $115.6M | $219.9M | ||
| Q3 25 | $124.5M | $205.6M | ||
| Q2 25 | $124.0M | $203.1M | ||
| Q1 25 | $103.6M | $193.6M | ||
| Q4 24 | $101.6M | $215.7M | ||
| Q3 24 | $112.8M | $196.6M | ||
| Q2 24 | $112.6M | $198.6M | ||
| Q1 24 | $95.6M | $188.6M |
净利润KRTOFIX
| Q4 25 | $6.8M | $-2.2M | ||
| Q3 25 | $7.3M | $-22.8M | ||
| Q2 25 | $10.9M | $-14.1M | ||
| Q1 25 | $6.4M | $-53.1M | ||
| Q4 24 | $5.6M | $-29.1M | ||
| Q3 24 | $9.1M | $-27.4M | ||
| Q2 24 | $9.1M | $-33.4M | ||
| Q1 24 | $6.2M | $-36.0M |
毛利率KRTOFIX
| Q4 25 | 34.0% | 71.1% | ||
| Q3 25 | 34.5% | 72.2% | ||
| Q2 25 | 39.6% | 68.7% | ||
| Q1 25 | 39.3% | 62.8% | ||
| Q4 24 | 39.2% | 69.0% | ||
| Q3 24 | 38.6% | 68.7% | ||
| Q2 24 | 38.5% | 67.8% | ||
| Q1 24 | 39.3% | 67.5% |
营业利润率KRTOFIX
| Q4 25 | 7.3% | 0.2% | ||
| Q3 25 | 6.9% | -8.3% | ||
| Q2 25 | 13.3% | -7.9% | ||
| Q1 25 | 7.5% | -25.2% | ||
| Q4 24 | 7.2% | -5.3% | ||
| Q3 24 | 10.0% | -9.6% | ||
| Q2 24 | 9.9% | -12.5% | ||
| Q1 24 | 8.4% | -15.6% |
净利率KRTOFIX
| Q4 25 | 5.9% | -1.0% | ||
| Q3 25 | 5.9% | -11.1% | ||
| Q2 25 | 8.8% | -6.9% | ||
| Q1 25 | 6.2% | -27.4% | ||
| Q4 24 | 5.5% | -13.5% | ||
| Q3 24 | 8.1% | -13.9% | ||
| Q2 24 | 8.1% | -16.8% | ||
| Q1 24 | 6.4% | -19.1% |
每股收益（稀释后）KRTOFIX
| Q4 25 | $0.34 | $-0.05 | ||
| Q3 25 | $0.36 | $-0.57 | ||
| Q2 25 | $0.54 | $-0.36 | ||
| Q1 25 | $0.32 | $-1.35 | ||
| Q4 24 | $0.28 | $-0.76 | ||
| Q3 24 | $0.45 | $-0.71 | ||
| Q2 24 | $0.45 | $-0.88 | ||
| Q1 24 | $0.31 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.9M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $149.4M | $450.0M |
| 总资产 | $287.7M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRTOFIX
| Q4 25 | $37.9M | $82.0M | ||
| Q3 25 | $44.0M | $62.9M | ||
| Q2 25 | $57.0M | $65.6M | ||
| Q1 25 | $56.3M | $58.0M | ||
| Q4 24 | $59.9M | $83.2M | ||
| Q3 24 | $60.4M | $30.1M | ||
| Q2 24 | $52.1M | $26.4M | ||
| Q1 24 | $46.7M | $27.0M |
总债务KRTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益KRTOFIX
| Q4 25 | $149.4M | $450.0M | ||
| Q3 25 | $154.5M | $442.5M | ||
| Q2 25 | $155.8M | $458.3M | ||
| Q1 25 | $153.3M | $458.3M | ||
| Q4 24 | $155.6M | $503.1M | ||
| Q3 24 | $157.3M | $525.9M | ||
| Q2 24 | $157.7M | $546.0M | ||
| Q1 24 | $154.4M | $570.3M |
总资产KRTOFIX
| Q4 25 | $287.7M | $850.6M | ||
| Q3 25 | $302.8M | $832.6M | ||
| Q2 25 | $321.0M | $837.2M | ||
| Q1 25 | $312.2M | $823.1M | ||
| Q4 24 | $294.5M | $893.3M | ||
| Q3 24 | $306.8M | $867.9M | ||
| Q2 24 | $310.7M | $882.0M | ||
| Q1 24 | $279.0M | $906.0M |
负债/权益比KRTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $15.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 13.1% | 7.6% |
| 资本支出强度资本支出/营收 | 0.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 2.26× | — |
| 过去12个月自由现金流最近4个季度 | $33.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流KRTOFIX
| Q4 25 | $15.4M | $27.7M | ||
| Q3 25 | $982.0K | $12.4M | ||
| Q2 25 | $9.8M | $11.6M | ||
| Q1 25 | $7.7M | $-18.4M | ||
| Q4 24 | $8.3M | $23.7M | ||
| Q3 24 | $19.5M | $11.7M | ||
| Q2 24 | $13.7M | $9.0M | ||
| Q1 24 | $6.6M | $-18.6M |
自由现金流KRTOFIX
| Q4 25 | $15.1M | $16.8M | ||
| Q3 25 | $736.0K | $2.5M | ||
| Q2 25 | $9.6M | $4.5M | ||
| Q1 25 | $7.6M | $-25.1M | ||
| Q4 24 | $8.0M | $15.2M | ||
| Q3 24 | $19.2M | $6.3M | ||
| Q2 24 | $13.4M | $-360.0K | ||
| Q1 24 | $6.4M | $-29.1M |
自由现金流率KRTOFIX
| Q4 25 | 13.1% | 7.6% | ||
| Q3 25 | 0.6% | 1.2% | ||
| Q2 25 | 7.7% | 2.2% | ||
| Q1 25 | 7.4% | -13.0% | ||
| Q4 24 | 7.9% | 7.0% | ||
| Q3 24 | 17.0% | 3.2% | ||
| Q2 24 | 11.9% | -0.2% | ||
| Q1 24 | 6.7% | -15.4% |
资本支出强度KRTOFIX
| Q4 25 | 0.2% | 4.9% | ||
| Q3 25 | 0.2% | 4.8% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.1% | 3.5% | ||
| Q4 24 | 0.2% | 4.0% | ||
| Q3 24 | 0.3% | 2.7% | ||
| Q2 24 | 0.2% | 4.7% | ||
| Q1 24 | 0.2% | 5.6% |
现金转化率KRTOFIX
| Q4 25 | 2.26× | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRT
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
